Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Press release

BioStock: Biosergen taps antifungal expert as board member

Biosergen

Biosergen, a biotech company focused on developing treatments for life-threatening fungal infections, has nominated Dr. Marco Taglietti, M.D., for election to its board at the upcoming annual general meeting. With extensive experience in antifungal drug development and global licensing, Dr. Taglietti’s expertise aligns with Biosergen’s ongoing clinical progress with BSG005, currently in a proof-of-concept study for patients unresponsive to standard therapies.

Read the full article at biostock.se:

https://www.biostock.se/en/2025/05/biosergen-taps-antifungal-expert-as-board-member/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.